Manageable risks for dementia and heart disease are closely linked, AHA’s annual report finds
By
Alicia Lasek
Jan 27, 2022
There is growing evidence that what is good for the heart is good for the brain. But that knowledge and awareness has not yet trickled down to patients, the authors say.
Study: Assumption endures that Black LTC residents’ proxies reluctant to engage in advance care planning
By
Alicia Lasek
Jan 27, 2022
Investigators have found a persistent assumption among nursing home clinicians, administrators and other staff that Black residents’ families prefer more intensive end-of-life interventions.
Clinical briefs for Thursday, Jan. 27
By
Alicia Lasek
Jan 27, 2022
CMS: Only fully vaccinated surveyors should be part of on-site survey teams … CMS begins posting more staffing and turnover data … Senators sponsor bipartisan bill to probe handling of U.S. pandemic...
FDA halts use of REGEN-COV, Eli Lilly monoclonal antibodies
By
Alicia Lasek
Jan 26, 2022
The Food and Drug Administration has revoked its emergency use authorizations for two monoclonal antibody cocktails that have served as COVID-19 treatment mainstays in long-term care facilities.
It’s official: Omicron causes less severe COVID-19 illness than prior variants, CDC study finds
By
Alicia Lasek
Jan 26, 2022
The SARS-CoV-2 omicron variant is much less likely to cause severe illness and death than its predecessors, according to a new analysis of U.S. data from December 2020 through mid-January 2022.
Dietary protein often too high in seniors with kidney disease, nephrologists say
By
Alicia Lasek
Jan 26, 2022
Study results underscore the need for a thorough nutritional review and intervention in this population, investigators say.
Clinical briefs for Wednesday, Jan. 26
By
Alicia Lasek
Jan 26, 2022
OSHA to withdraw COVID-19 vaccine mandate … Infected CNAs recount going to work sick at short-staffed California nursing homes … Trail of loss is following omicron’s peak … Pfizer working on a...
FDA expands use of remdesivir to skilled nursing, other non-hospital settings
By
Alicia Lasek
Jan 25, 2022
Remdesivir, the first FDA-approved COVID-19 drug, now can be used in adult and pediatric patients with mild-to moderate COVID-19 illness at high risk of progressing to severe disease, the agency has announced.
NIH panel updates treatment guidelines for non-hospitalized COVID-19 patients
By
Alicia Lasek
Jan 25, 2022
A new recommended treatments list addresses the omicron variant’s current dominance and drug supply shortages.
Pharmacists poised to continue transition into direct care roles, survey finds
By
Alicia Lasek
Jan 25, 2022
Pharmacists will continue to move into central roles in healthcare, including chronic disease management in the adult patient population, the authors say.